Idexx Laboratories Inc /De (IDXX) — 8-K Filings

8-K Filings (19)

• IDEXX Updates Executive Compensation; Filed 8-K on 2026-03-26 — Mar 26, 2026
  IDEXX Laboratories Inc. filed an 8-K on March 26, 2026, reporting changes in its executive compensation structure under Item 5.02. This filing indicates that th
• IDEXX Laboratories Enters Material Definitive Agreement — Nov 13, 2025 Risk: medium
  On November 12, 2025, IDEXX Laboratories, Inc. entered into a material definitive agreement, which also created a direct financial obligation for the company. T
• IDEXX LABORATORIES Files 8-K on Financials — Nov 3, 2025 Risk: low
  On November 3, 2025, IDEXX LABORATORIES, INC. filed an 8-K report with the SEC. The filing pertains to the company's results of operations and financial conditi
• IDEXX Laboratories Reports Director Departure and Officer Changes — Oct 7, 2025 Risk: low
  On October 6, 2025, IDEXX Laboratories, Inc. reported a departure of a director, effective October 6, 2025. The filing also announced the election of new direct
• IDEXX Laboratories Files 8-K on Financials — Aug 4, 2025 Risk: low
  On August 4, 2025, IDEXX Laboratories, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as w
• IDEXX LABORATORIES Files 8-K on Director and Officer Changes — Jul 10, 2025 Risk: low
  On July 10, 2025, IDEXX LABORATORIES, INC. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing i
• IDEXX LABORATORIES Files 8-K: Corporate Actions & Shareholder Votes — May 9, 2025 Risk: low
  On May 7, 2025, IDEXX LABORATORIES, INC. filed an 8-K report detailing several key events. The company submitted matters to a vote of its security holders and i
• IDEXX Laboratories Files 8-K on Financials — May 1, 2025 Risk: low
  IDEXX Laboratories, Inc. filed an 8-K on May 1, 2025, reporting on its results of operations and financial condition. The filing also includes financial stateme
• IDEXX Laboratories Announces Board Changes — Feb 14, 2025 Risk: low
  On February 13, 2025, IDEXX Laboratories, Inc. reported a change in its board of directors. Specifically, the company announced the departure of director Michae
• IDEXX LABORATORIES Files 8-K on Financials — Feb 3, 2025 Risk: low
  On February 3, 2025, IDEXX LABORATORIES, INC. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as
• IDEXX LABORATORIES Reports Officer/Director Changes & Compensation Updates — Dec 12, 2024 Risk: medium
  IDEXX LABORATORIES, INC. (IDXX) filed an 8-K on December 12, 2024, reporting changes effective December 6, 2024. The filing details the departure of certain off
• IDEXX Laboratories Files 8-K Report — Dec 9, 2024 Risk: low
  On December 3, 2024, IDEXX Laboratories, Inc. filed an 8-K report to disclose other events and financial statements/exhibits. The filing does not contain specif
• IDEXX Labs Appoints New Chief Medical Officer — Nov 21, 2024 Risk: low
  IDEXX Laboratories, Inc. announced on November 20, 2024, the appointment of Dr. Michael J. McGeary as Chief Medical Officer, effective November 18, 2024. Dr. Mc
• IDEXX Laboratories Reports Director/Officer Changes & Financials — Nov 12, 2024 Risk: low
  IDEXX Laboratories, Inc. filed an 8-K on November 12, 2024, reporting on the departure of directors or certain officers, the election of directors, the appointm
• IDEXX LABORATORIES REPORTS MATERIAL AGREEMENT — Nov 6, 2024 Risk: medium
  IDEXX LABORATORIES, INC. (IDXX) filed an 8-K on November 6, 2024, reporting the entry into a material definitive agreement as of October 31, 2024. The filing do
• IDEXX Laboratories Files 8-K on Financials — Aug 6, 2024 Risk: low
  On August 6, 2024, IDEXX Laboratories, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as w
• IDEXX Laboratories Files 8-K on Officer Changes and Shareholder Votes — May 10, 2024 Risk: low
  IDEXX Laboratories, Inc. filed an 8-K on May 10, 2024, reporting events as of May 6, 2024. The filing covers the departure of directors or certain officers, the
• IDEXX Laboratories Files 8-K on Financials — May 1, 2024 Risk: low
  On May 1, 2024, IDEXX Laboratories, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well
• IDEXX Files 8-K on Financial Condition, Operations — Feb 5, 2024
  IDEXX Laboratories, Inc. (IDXX) filed an 8-K on February 5, 2024, to report on its results of operations and financial condition, as well as to include financia

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX